TMS treatment plus CBIT study for Tourette’s tics
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests whether a treatment called TMS, added to an evidence-based therapy called CBIT, can reduce Tourette’s tics more than CBIT alone. You may be assigned to different study groups, and they will also use brain imaging to measure changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have a diagnosis of Tourette syndrome
- Have moderate tic severity at the start of the study
- You must be able to participate in CBIT (behavior therapy for tics)
- You must be able to safely get an MRI/fMRI scan
- Not be pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining a brain stimulation technique called TMS with behavioral therapy can reduce tics in adolescents and young adults. If you have had tics for at least a year and they are moderate or severe, this trial may be a good fit.
This study tests a behavioral therapy (CBIT) for children with tics. It uses brain scans (MRI and EEG) to see how the therapy works. It may be a good fit for a child who has had tics for at least a year and hasn't had much of this therapy before.
This study looks at brain activity in people with Tourette syndrome who are already receiving deep brain stimulation (a treatment that uses electrical pulses to help control tics). The goal is to learn more about the brain signals linked to tics, which could help improve future treatments.
This trial tests a talking therapy that helps manage tics by changing thoughts and feelings. Some people also get biofeedback, which uses sensors to help control body responses. Researchers want to see which approach works better for reducing tics in teens and young adults with Tourette's syndrome or bothersome tics.
This Phase 2 trial tests SCI-110 to reduce Tourette syndrome tics. It may help people whose tics are moderate to severe while they take the study medicine and continue (or keep steady) their usual tic treatments.
This trial tests a brain stimulation device (RNS) for people with Tourette's syndrome whose symptoms haven't improved with standard treatments. It aims to see if this approach can reduce tics and improve quality of life.
Hear when a new Tourette Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.